Methylphenidate
- Generic Name
- Methylphenidate
- Brand Names
- Adhansia, Aptensio, Biphentin, Concerta, Cotempla, Daytrana, Foquest, Jornay, Metadate, Methylin, Quillichew, Quillivant, Relexxii, Ritalin
- Drug Type
- Small Molecule
- Chemical Formula
- C14H19NO2
- CAS Number
- 113-45-1
- Unique Ingredient Identifier
- 207ZZ9QZ49
- Background
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and for narcolepsy. Also known as the marketed products Ritalin, Concerta, or Biphentin, methylphenidate is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc) to improve ...
- Indication
Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy
- Associated Therapies
- -
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
- Conditions
- Interventions
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2019-04-23
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 124
- Registration Number
- NCT00136734
- Locations
- 🇺🇸
Research Foundation for Mental Hygiene, Inc., New York, New York, United States
Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
- Conditions
- Interventions
- First Posted Date
- 2005-08-11
- Last Posted Date
- 2015-04-24
- Lead Sponsor
- US Department of Veterans Affairs
- Target Recruit Count
- 47
- Registration Number
- NCT00129467
- Locations
- 🇺🇸
VA Portland Health Care System, Portland, OR, Portland, Oregon, United States
Methylphenidate in Treating Patients With Melanoma
- Conditions
- First Posted Date
- 2003-10-28
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 200
- Registration Number
- NCT00003266
- Locations
- 🇺🇸
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1
- Conditions
- Interventions
- First Posted Date
- 2003-05-22
- Last Posted Date
- 2019-04-23
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 115
- Registration Number
- NCT00061087
- Locations
- 🇺🇸
Research Foundation for Mental Hygiene, Inc., New York, New York, United States
Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2021-09-09
- Lead Sponsor
- Wake Forest University Health Sciences
- Registration Number
- NCT00031798
- Locations
- 🇺🇸
CCOP - Western Regional, Arizona, Phoenix, Arizona, United States
🇺🇸CCOP - Upstate Carolina, Spartanburg, South Carolina, United States
🇺🇸CCOP - Central Illinois, Decatur, Illinois, United States
Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery
- Conditions
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Registration Number
- NCT00035139
- Locations
- 🇺🇸
Childrens Hospital Of Philadelphia, Philadelphia, Pennsylvania, United States
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
- Conditions
- Interventions
- First Posted Date
- 2002-03-05
- Last Posted Date
- 2009-05-21
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 122
- Registration Number
- NCT00031395
- Locations
- 🇺🇸
Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States
🇺🇸University of Rochester, Department of Neurology, Rochester, New York, United States
Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders
- Conditions
- First Posted Date
- 2001-10-24
- Last Posted Date
- 2009-07-28
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 60
- Registration Number
- NCT00025779
- Locations
- 🇺🇸
Indiana University-Riley Hospital for Children, Indianapolis, Indiana, United States
🇺🇸UCLA Neuropsychiatric Institute, Los Angeles, California, United States
🇺🇸Kennedy Krieger Institute, Baltimore, Maryland, United States
Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)
- Conditions
- First Posted Date
- 2001-07-09
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 165
- Registration Number
- NCT00018863
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
🇺🇸New York University School of Medicine, New York, New York, United States
🇺🇸University of California, Irvine, Irvine, California, United States
Cocaine-Methylphendidate Interaction Study - 4
- Conditions
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 8
- Registration Number
- NCT00015067
- Locations
- 🇺🇸
Cincinnati MDRU, Cincinnati, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.